Shanghai ShenQi Pharmaceutical Co., Ltd. logo

Shanghai ShenQi Pharmaceutical Co., Ltd. (600613)

Market Closed
11 Aug, 06:57
SSE SSE
¥
5. 17
-0.02
-0.3854%
¥
3.31B Market Cap
- P/E Ratio
0.4% Div Yield
10.29M Volume
- Eps
¥ 5.19
Previous Close
Add Transaction
Day Range
5.16 5.26
Year Range
4.33 7.53
Want to track 600613 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600613 closed today lower at ¥5.17, a decrease of -0.3854% from yesterday's close, completing a monthly increase of 16.4414% or ¥0.73. Over the past 12 months, 600613 stock lost -15.1067%.
600613 pays dividends to its shareholders, with the most recent payment made on Jun 17, 2026. The next estimated payment will be in In 10 months on Jun 17, 2027 for a total of ¥0.07.
The last earnings report, released on May 20, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.027%, based on the last three reports.
Shanghai ShenQi Pharmaceutical Co., Ltd. has completed 7 stock splits, with the recent split occurring on Jul 06, 2015.
The company's stock is traded on one exchange.

600613 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Shanghai ShenQi Pharmaceutical Co., Ltd. (600613) FAQ

What is the stock price today?

The current price is ¥5.17.

On which exchange is it traded?

Shanghai ShenQi Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600613.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, the market cap is 3.31B.

Has Shanghai ShenQi Pharmaceutical Co., Ltd. ever had a stock split?

Shanghai ShenQi Pharmaceutical Co., Ltd. had 7 splits and the recent split was on Jul 06, 2015.

Shanghai ShenQi Pharmaceutical Co., Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Feng Bin CEO
SSE Exchange
CNE000000453 ISIN
CN Country
1,426 Employees
17 Jun 2026 Last Dividend
27 Jul 2006 Last Split
20 Jun 1992 IPO Date

Overview

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. operates as a powerhouse in the pharmaceutical sector within China, acting as a holding investment company with a keen focus on pharmaceutical manufacturing. Established in 1990 and rooted in Shanghai, China, the company has established itself as a prominent player in the development and production of a wide range of pharmaceutical products. Its operations span across various therapeutic areas, including anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, nourishing and soothing, tonic products, as well as treatments for cold and cough, children's medicine, anti-fungal, and gynecology, among others. Through its subsidiaries, Shanghai Shenqi not only emphasizes the importance of research and development in crafting effective solutions for a multitude of health issues but also ensures the availability of these solutions both as prescription drugs and over-the-counter (OTC) products to meet diverse healthcare needs.

Products and Services

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. offers an extensive portfolio of products and services aimed at improving patient health and well-being across various medical conditions:

  • Sodium Cantharidate Vitamin B6 Injection: A specialized formulation used in the treatment of certain cancer types, highlighting the company's expertise in anti-tumor medications.
  • Sodium Cantharidate Injection: Another cancer-fighting product, underlining the firm's commitment to combatting oncological diseases with innovative solutions.
  • Loquat Cough Granules: An effective remedy for coughs, part of their cold and cough treatment range, utilizing traditional herbal ingredients.
  • Strong Loquat Decoction: A potent version of the loquat formulation designed to provide relief from more severe coughs and respiratory discomfort.
  • Loquat Cough Capsules: Capsule-form cough relief, offering a convenient option for individuals seeking remedies for cough and respiratory issues.
  • Jinwugutong Capsules: A solution targeted at relieving rheumatism and bone pain, showcasing Shanghai Shenqi’s dedication to providing relief for musculoskeletal conditions.
  • Coral Ringworm Jing: An anti-fungal treatment, part of the company’s range of products addressing fungal infections.
  • Jingwu Capsules: Formulated for various therapeutic needs, encapsulating the company’s broad approach to healthcare solutions.
  • Quantianma Capsules: Designed for the nourishing and soothing category, these capsules highlight the company’s focus on holistic health and wellness.
  • Yindanxintai Dropping Pills: Part of the cardiovascular portfolio, these pills aim to support heart health, reflecting the firm's investment in cardio-protective treatments.

Contact Information

Address: Changfa Building, Shanghai, China, 200003
Phone: 86 21 5375 0009